This study aimed to characterize the effects of corrector MCG1516A both in cell lines constitutively expressing WT-, F508del-CFTR, and several other CF-causing mutations and in intestinal organoids (F508del/F508del genotype). The gene discussed is CFTR; the disease is cystic fibrosis.